Access the full text.
Sign up today, get DeepDyve free for 14 days.
P. Hoodless, T. Haerry, S. Abdollah, M. Stapleton, M. O’Connor, L. Attisano, J. Wrana (1996)
MADR1, a MAD-Related Protein That Functions in BMP2 Signaling PathwaysCell, 85
M. Matzuk, Allan Bradley (1992)
Cloning of the human activin receptor cDNA reveals high evolutionary conservation.Biochimica et biophysica acta, 1130 1
M. Abe, J. Harpel, C. Metz, I. Nunes, D. Loskutoff, D. Rifkin (1994)
An assay for transforming growth factor-beta using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct.Analytical biochemistry, 216 2
A. Thomson (1994)
The cytokine handbook
Kolja Eppert, S. Scherer, H. Ozçelik, R. Pirone, P. Hoodless, Hyeja Kim, L. Tsui, B. Bapat, S. Gallinger, I. Andrulis, G. Thomsen, J. Wrana, L. Attisano (1996)
MADR2 Maps to 18q21 and Encodes a TGFβ–Regulated MAD–Related Protein That Is Functionally Mutated in Colorectal CarcinomaCell, 86
R. Derynck (1994)
TGF-β-receptor-mediated signalingTrends in Biochemical Sciences, 19
J. Graff, A. Bansal, D. Melton (1996)
Xenopus Mad Proteins Transduce Distinct Subsets of Signals for the TGFβ SuperfamilyCell, 85
R. Ebner, Ruey-Hwa Chen, L. Shum, S. Lawler, T. Zioncheck, Angeline Lee, A. Lopez, R. Derynck (1993)
Cloning of a type I TGF-beta receptor and its effect on TGF-beta binding to the type II receptor.Science, 260 5112
J. Baker, R. Harland (1996)
A novel mesoderm inducer, Madr2, functions in the activin signal transduction pathway.Genes & development, 10 15
Xin-Hua Feng, E. Filvaroff, R. Derynck (1995)
Transforming Growth Factor-β (TGF-β)-induced Down-regulation of Cyclin A Expression Requires a Functional TGF-β Receptor ComplexThe Journal of Biological Chemistry, 270
B. Like, J. Massagué (1986)
The antiproliferative effect of type beta transforming growth factor occurs at a level distal from receptors for growth-activating factors.The Journal of biological chemistry, 261 29
F. Weis-Garcia, J. Massagué (1996)
Complementation between kinase‐defective and activation‐defective TGF‐beta receptors reveals a novel form of receptor cooperativity essential for signaling.The EMBO Journal, 15
J. Sekelsky, S. Newfeld, L. Raftery, E. Chartoff, W. Gelbart (1995)
Genetic characterization and cloning of mothers against dpp, a gene required for decapentaplegic function in Drosophila melanogaster.Genetics, 139 3
G. Lennon, C. Auffray, M. Polymeropoulos, M. Soares (1996)
The I.M.A.G.E. Consortium: an integrated molecular analysis of genomes and their expression.Genomics, 33 1
S. Markowitz, Jing Wang, L. Myeroff, R. Parsons, L. Sun, J. Lutterbaugh, R. Fan, E. Zborowska, K. Kinzler, B. Vogelstein, B. Vogelstein, M. Brattain, J. Willson (1995)
Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability.Science, 268 5215
Michele Goyette, Kathleen Cho, C. Fasching, D. Levy, K. Kinzler, C. Paraskeva, B. Vogelstein, E. Stanbridge (1992)
Progression of colorectal cancer is associated with multiple tumor suppressor gene defects but inhibition of tumorigenicity is accomplished by correction of any single defect via chromosome transferMolecular and Cellular Biology, 12
J. Ihle (1995)
Cytokine receptor signallingNature, 377
K. Arora, Heng Dai, S. Kazuko, J. Jamal, M. O’Connor, A. Letsou, R. Warrior (1995)
The drosophila schnurri gene acts in the Dpp/TGFβ signaling pathway and encodes a transcription factor homologous to the human MBP familyCell, 81
J. Celis, R. Barrio, F. Kafatos (1996)
A gene complex acting downstream of dpp in Drosophila wing morphogenesisNature, 381
J. Massagué, L. Attisano, J. Wrana (1994)
The TGF-β family and its composite receptorsTrends in Cell Biology, 4
M. Laiho, J. Decaprio, J. Ludlow, D. Livingston, J. Massagué (1990)
Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylationCell, 62
Ruey-Hwa Chen, P. Miettinen, E. Maruoka, L. Choy, R. Derynck (1995)
A WD-domain protein that is associated with and phosphorylated by the type II TGF-β receptorNature, 377
Herbert Lin, Xiao-Fan Wang, E. Ng-Eaton, R. Weinberg, H. Lodish (1992)
Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinaseCell, 68
Fang Liu, A. Hata, J. Baker, J. Doody, J. Cárcamo, R. Harland, J. Massagué (1996)
A human Mad protein acting as a BMP-regulated transcriptional activatorNature, 381
J. Wrana, L. Attisano, J. Cárcamo, A. Zentella, J. Doody, M. Laiho, Xiao-Fan Wang, J. Massagué (1992)
TGFβ signals through a heteromeric protein kinase receptor complexCell, 71
D. Smith, K. Johnson (1988)
Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase.Gene, 67 1
D. Kingsley (1994)
The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms.Genes & development, 8 2
N. Grieder, Denise Nellen, Richard Burke, K. Basler, M. Affolter (1995)
schnurri is required for drosophila Dpp signaling and encodes a zinc finger protein similar to the mammalian transcription factor PRDII-BF1Cell, 81
S. Hahn, M. Schutte, A. Hoque, C. Moskaluk, L. Costa, E. Rozenblum, Craig Weinstein, Aryeh Fischer, C. Yeo, R. Hruban, S. Kern (1996)
DPC4, A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1Science, 271
M. Keeton, S. Curriden, A. Zonneveld, D. Loskutoff (1991)
Identification of regulatory sequences in the type 1 plasminogen activator inhibitor gene responsive to transforming growth factor beta.The Journal of biological chemistry, 266 34
TRANSFORMING growth factor-β TGF-β is the prototype for a family of extracellular proteins that affect cell proliferation and tissue differentiation1–3. TGF-β-related factors, including BMP-2/4, Dpp and activin, act through two types of serine/threonine kinase receptors which can form a heteromeric complex3,4. However, the mechanism of signal transduction by these receptors is largely unknown. In Drosophila, Mad is required for signalling by Dpp5. We have isolated complementary DNAs for four human Mad homologues, one of which, hMAD-4, is identical to DPC-4, a candidate tumour suppressor6. hMAD-3 and -4 synergized to induce strong ligand-independent TGF-β-like responses. When truncated at their carboxy termini, hMAD-3 and -4 act as dominant-negative inhibitors of the normal TGF-β response. The activity of hMAD-3 and -4 was regulated by the TGF-β receptors, and hMAD-3 but not hMAD-4 was phosphorylated and associated with the ligand-bound receptor complex. These results define hMAD-3 and -4 as effectors of the TGF-β response and demonstrate a function for DPC-4/hMAD-4 as a tumour suppressor.
Nature – Springer Journals
Published: Sep 12, 1996
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.